# Elena Garal‐Pantaler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/elena-garal-pantaler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 304 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 5 |
| i10-index | 2 |
| Last Known Institution | DAK-Gesundheit (Germany) |
| OpenAlex ID | https://openalex.org/A5045288701 |
| ORCID iD | 0009-0005-5285-6913 |
| Works | 13 |

## Researcher papers

- [Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study](https://scholariq.org/papers/heart-failure-and-chronic-kidney-disease-manifestation-and-mortality-risk/)
- [The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization](https://scholariq.org/papers/the-burden-of-systemic-lupus-erythematosus-in-germany-incidence-prevalence-and/)
- [Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis](https://scholariq.org/papers/real-world-burden-of-immunosuppressant-treated-lupus-nephritis-a-german-claims/)
- [Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany](https://scholariq.org/papers/clinical-and-economic-burden-of-organ-damage-among-patients-with-systemic-lupus/)
- [Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data](https://scholariq.org/papers/hepatocellular-carcinoma-after-prior-sorafenib-treatment-incidence-healthcare/)
- [A Retrospective Observational Study of the Epidemiology of Advanced Gastric Cancer in Germany](https://scholariq.org/papers/a-retrospective-observational-study-of-the-epidemiology-of-advanced-gastric/)
- [PS8:160 Health care resource use (hru) and medical cost analyses as a function of systemic lupus erythematosus (sle) disease severity: analysis of claims data of a german sickness fund](https://scholariq.org/papers/ps8-160-health-care-resource-use-hru-and-medical-cost-analyses-as-a-function-of/)
- [MO505: Prevalence of Lupus Nephritis Among Patients With Systemic Lupus Erythematosus In Germany](https://scholariq.org/papers/mo505-prevalence-of-lupus-nephritis-among-patients-with-systemic-lupus/)
- [The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany](https://scholariq.org/papers/the-impact-of-systemic-lupus-erythematosus-flares-on-clinical-and-economic/)
- [P804 Retrospective observational claims data analysis of German statutory health insurance (SHI) patients with Crohn’s disease reveals low prevalence of perianal fistulas (3.4%), but high rates of biologic treatment and inpatient surgical intervention](https://scholariq.org/papers/p804-retrospective-observational-claims-data-analysis-of-german-statutory-health/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)

## Researcher university

- [DAK-Gesundheit (Germany)](https://scholariq.org/institutions/dak-gesundheit-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.